This Week’s Biotech Highlights
With our friends south of the border still reeling from a turkey-induced hangover, it was a quiet week. Still, there was plenty to be thankful for.
Proponents of personalized medicine were thankful for several developments that show this trend is picking up speed: CVS followed Medco’s example in expanding pharmacogenomic testing, while biotech and pharma companies, as well as the National Cancer Institute, stepped up their investment in the field.
I am thankful to be following a new trend for 2010: synthetic biology, i.e. attempts to create novel organisms. This week, I weighed in on the search for . . . [more]
